Published in Lancet Infect Dis on June 01, 2004
The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (2005) 31.73
A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med (2009) 12.82
Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol (2005) 11.88
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med (2008) 8.95
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med (2005) 8.36
Shrinking the malaria map: progress and prospects. Lancet (2010) 8.21
Determining global population distribution: methods, applications and data. Adv Parasitol (2006) 7.53
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med (2008) 7.28
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med (2008) 6.61
Host range and emerging and reemerging pathogens. Emerg Infect Dis (2005) 5.90
The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature (2005) 5.71
The malaria Atlas Project: developing global maps of malaria risk. PLoS Med (2006) 5.51
Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med (2008) 5.29
Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med (2010) 4.89
The accuracy of human population maps for public health application. Trop Med Int Health (2005) 4.64
Mapping the global extent of malaria in 2005. Trends Parasitol (2006) 4.43
Ranking of elimination feasibility between malaria-endemic countries. Lancet (2010) 4.05
A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia. PLoS Med (2008) 3.97
Knowlesi malaria: newly emergent and of public health importance? Trends Parasitol (2008) 3.66
Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A (2015) 3.46
Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project. Malar J (2007) 3.42
Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev (2009) 3.41
Assessing the accuracy of satellite derived global and national urban maps in Kenya. Remote Sens Environ (2005) 3.33
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin Infect Dis (2007) 3.27
The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med (2005) 3.15
Modelling malaria risk in East Africa at high-spatial resolution. Trop Med Int Health (2005) 3.15
Climate change and the global malaria recession. Nature (2010) 3.10
Artemisinin combination therapy for vivax malaria. Lancet Infect Dis (2010) 3.08
Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ (2005) 3.05
Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis (2007) 3.02
Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods. PLoS Med (2011) 2.74
Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS One (2007) 2.66
Interdependence of domestic malaria prevention measures and mosquito-human interactions in urban Dar es Salaam, Tanzania. Malar J (2007) 2.57
Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun (2010) 2.46
Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study. PLoS Med (2013) 2.46
Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev (2013) 2.36
Defining the global spatial limits of malaria transmission in 2005. Adv Parasitol (2006) 2.35
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin Trials (2006) 2.33
The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci U S A (2008) 2.33
A global assessment of closed forests, deforestation and malaria risk. Ann Trop Med Parasitol (2006) 2.22
Global transport networks and infectious disease spread. Adv Parasitol (2006) 2.20
Prevalence and risk factors of malaria in Ethiopia. Malar J (2012) 2.19
Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar J (2005) 2.15
Clinical features of children hospitalized with malaria--a study from Bikaner, northwest India. Am J Trop Med Hyg (2010) 2.14
Quantifying aggregated uncertainty in Plasmodium falciparum malaria prevalence and populations at risk via efficient space-time geostatistical joint simulation. PLoS Comput Biol (2010) 2.07
Molecular identification of a malaria merozoite surface sheddase. PLoS Pathog (2005) 2.06
Plasmodium vivax: who cares? Malar J (2008) 1.98
Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput Biol (2007) 1.87
Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob Agents Chemother (2008) 1.86
Call to action: priorities for malaria elimination. Lancet (2010) 1.85
Spatial and temporal distribution of falciparum malaria in China. Malar J (2009) 1.79
Worldmapper: the human anatomy of a small planet. PLoS Med (2007) 1.78
The effects of spatial population dataset choice on estimates of population at risk of disease. Popul Health Metr (2011) 1.69
Large-scale spatial population databases in infectious disease research. Int J Health Geogr (2012) 1.68
Severe falciparum malaria in young children of the Kassena-Nankana district of northern Ghana. Malar J (2007) 1.67
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area. PLoS One (2009) 1.66
The relationship between the Plasmodium falciparum parasite ratio in childhood and climate estimates of malaria transmission in Kenya. Malar J (2004) 1.65
An Updating System for the Gridded Population Database of China Based on Remote Sensing, GIS and Spatial Database Technologies. Sensors (Basel) (2009) 1.63
PfCRT and its role in antimalarial drug resistance. Trends Parasitol (2012) 1.63
Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations. Malar J (2009) 1.62
Ten year trend analysis of malaria prevalence in Kola Diba, North Gondar, Northwest Ethiopia. Parasit Vectors (2012) 1.60
Malaria and water resource development: the case of Gilgel-Gibe hydroelectric dam in Ethiopia. Malar J (2009) 1.60
Use of Bayesian geostatistical prediction to estimate local variations in Schistosoma haematobium infection in western Africa. Bull World Health Organ (2009) 1.57
Anopheles gambiae APL1 is a family of variable LRR proteins required for Rel1-mediated protection from the malaria parasite, Plasmodium berghei. PLoS One (2008) 1.55
Lessons from malaria control to help meet the rising challenge of dengue. Lancet Infect Dis (2012) 1.54
Malaria vector control: from past to future. Parasitol Res (2011) 1.53
Global drivers of human pathogen richness and prevalence. Proc Biol Sci (2010) 1.51
Development of a new version of the Liverpool Malaria Model. I. Refining the parameter settings and mathematical formulation of basic processes based on a literature review. Malar J (2011) 1.45
Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan children. Malar J (2009) 1.43
A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan. PLoS One (2008) 1.43
Malaria's indirect contribution to all-cause mortality in the Andaman Islands during the colonial era. Lancet Infect Dis (2008) 1.40
Population, behavioural and environmental drivers of malaria prevalence in the Democratic Republic of Congo. Malar J (2011) 1.40
Colorimetric Detection of Plasmodium vivax in Urine Using MSP10 Oligonucleotides and Gold Nanoparticles. PLoS Negl Trop Dis (2016) 1.39
Ranking malaria risk factors to guide malaria control efforts in African highlands. PLoS One (2009) 1.38
Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J (2013) 1.37
Resistance to chloroquine unhinges vivax malaria therapeutics. Antimicrob Agents Chemother (2011) 1.34
The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. PLoS Med (2010) 1.34
Can Anopheles gambiae be infected with Wolbachia pipientis? Insights from an in vitro system. Appl Environ Microbiol (2006) 1.33
Estimating the burden of malaria in pregnancy: a case study from rural Madhya Pradesh, India. Malar J (2009) 1.33
A sticky situation: the unexpected stability of malaria elimination. Philos Trans R Soc Lond B Biol Sci (2013) 1.32
Urbanization and the global malaria recession. Malar J (2013) 1.32
Plasmodium falciparum malaria endemicity in Indonesia in 2010. PLoS One (2011) 1.31
The virulent Wolbachia strain wMelPop efficiently establishes somatic infections in the malaria vector Anopheles gambiae. Appl Environ Microbiol (2009) 1.27
Safety of iron fortification and supplementation in malaria-endemic areas. Nestle Nutr Inst Workshop Ser (2012) 1.26
Single-nucleotide polymorphism, linkage disequilibrium and geographic structure in the malaria parasite Plasmodium vivax: prospects for genome-wide association studies. BMC Genet (2010) 1.24
Plasmodium vivax: induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites. PLoS One (2010) 1.23
Structure-based ligand design and the promise held for antiprotozoan drug discovery. J Biol Chem (2008) 1.22
Scaling up impact of malaria control programmes: a tale of events in Sub-Saharan Africa and People's Republic of China. Infect Dis Poverty (2012) 1.17
A low-cost repellent for malaria vectors in the Americas: results of two field trials in Guatemala and Peru. Malar J (2007) 1.16
Plasmodium vivax treatments: what are we looking for? Curr Opin Infect Dis (2011) 1.16
Spatiotemporal distribution of malaria and the association between its epidemic and climate factors in Hainan, China. Malar J (2010) 1.15
Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection. PLoS One (2012) 1.15
CD4+ CD25+ Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses? Infect Immun (2010) 1.14
Malaria research challenges in low prevalence settings. Malar J (2012) 1.14
The Global Distribution of Infant Mortality: A subnational spatial view. Popul Space Place (2008) 1.13
Increased risk for severe malaria in HIV-1-infected adults, Zambia. Emerg Infect Dis (2009) 1.13
Beyond mobile populations: a critical review of the literature on malaria and population mobility and suggestions for future directions. Malar J (2014) 1.13
The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon) (2003) 34.28
Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18
Where and why are 10 million children dying every year? Lancet (2003) 28.59
The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q (1971) 13.96
A climate-based distribution model of malaria transmission in sub-Saharan Africa. Parasitol Today (1999) 12.36
Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ (1999) 12.10
The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg (2001) 11.74
The economic burden of malaria. Am J Trop Med Hyg (2001) 11.14
The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg (2001) 8.21
Satellite imagery in the study and forecast of malaria. Nature (2002) 7.84
Climate change and the resurgence of malaria in the East African highlands. Nature (2002) 7.70
Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis (2002) 6.73
Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev (2002) 6.07
The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol (2002) 6.01
Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review. Trans R Soc Trop Med Hyg (2000) 5.45
The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg (2001) 5.22
Epidemiological basis of malaria control. Bull World Health Organ (1956) 4.99
Trends in infectious disease mortality in the United States during the 20th century. JAMA (1999) 4.97
Earth observation, geographic information systems and Plasmodium falciparum malaria in sub-Saharan Africa. Adv Parasitol (2000) 4.92
World-wide malaria distribution, prevalence, and control. Am J Trop Med Hyg (1956) 4.17
Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis (2003) 4.10
The past, present and future of childhood malaria mortality in Africa. Trends Parasitol (2001) 4.10
Early origin and recent expansion of Plasmodium falciparum. Science (2003) 4.07
Evolution of malaria in Africa for the past 40 years: impact of climatic and human factors. J Am Mosq Control Assoc (1998) 3.90
Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa? Lancet Infect Dis (2002) 3.79
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis (2002) 3.46
An analysis of the geographical distribution of Plasmodium ovale. Bull World Health Organ (1969) 3.39
The "roll back malaria" campaign. Science (1998) 3.27
Malaria mortality rates in South Asia and in Africa: implications for malaria control. Parasitol Today (1998) 3.17
A review of hyperendemic malaria. Trop Dis Bull (1950) 3.12
Hot topic or hot air? Climate change and malaria resurgence in East African highlands. Trends Parasitol (2002) 3.10
Global campaign to eradicate malaria. BMJ (2001) 3.06
Mapping the ranges and relative abundance of the two principal African malaria vectors, Anopheles gambiae sensu stricto and An. arabiensis, using climate data. Proc Biol Sci (1998) 3.02
Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia (1999) 3.00
Re-emergence of malaria in India. Indian J Med Res (1996) 2.93
Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? Trans R Soc Trop Med Hyg (2002) 2.63
The de novo selection of drug-resistant malaria parasites. Proc Biol Sci (2003) 2.63
Meeting international goals in child survival and HIV/AIDS. Lancet (2002) 2.55
Strategic emphases for tropical diseases research: a TDR perspective. Trends Parasitol (2002) 2.54
Health and the environment in the 1990s. Am J Public Health (1992) 2.48
Malaria and the work of WHO. Bull World Health Organ (1989) 2.45
World malaria situation in 1994. Part I. Population at risk. Wkly Epidemiol Rec (1997) 2.41
The potential impact of integrated malaria transmission control on entomologic inoculation rate in highly endemic areas. Am J Trop Med Hyg (2000) 2.40
Global Fund makes historic first round of payments. Lancet (2002) 2.23
The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos Trans R Soc Lond B Biol Sci (2002) 2.20
The economic payoffs of integrated malaria control in the Zambian copperbelt between 1930 and 1950. Trop Med Int Health (2002) 2.19
Roll back malaria? The scarcity of international aid for malaria control. Malar J (2003) 2.17
Species-eradication: The Eradication of Anopheles gambioe from Upper Egypt, 1942-1945. Bull World Health Organ (1948) 2.04
Suppression of transmission of malaria through source reduction: antianopheline measures applied in Israel, the United States, and Italy. Rev Infect Dis (1989) 1.97
Ten years' study (1955-64) of host selection by anopheline mosquitos. Bull World Health Organ (1966) 1.95
A model for the origins and spread of drug-resistant malaria. Parasitology (1997) 1.84
Heterogeneities of the malaria vectorial system in tropical Africa and their significance in malaria epidemiology and control. Bull World Health Organ (1984) 1.83
The origin of malaria: mixed messages from genetic diversity. Nat Rev Microbiol (2004) 1.68
The clay feet of the malaria giant and its African roots: hypotheses and inferences about origin, spread and control of Plasmodium falciparum. Parassitologia (1999) 1.63
The epidemiologic transition theory. J Epidemiol Community Health (1994) 1.55
Malaria control and the evolution of drug resistance: an intriguing link. Trends Parasitol (2003) 1.54
Sickle-cell trait in human biological and cultural evolution. Development of agriculture causing increased malaria is bound to gene-pool changes causing malaria reduction. Science (1967) 1.48
Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia. Southeast Asian J Trop Med Public Health (1999) 1.44
Will the Global Fund help roll back malaria in Africa? Lancet (2002) 1.43
A new global effort to control malaria. Science (2002) 1.29
Roll Back Malaria. Parassitologia (1999) 1.29
Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria. Int J Parasitol (2003) 1.26
Malaria and ecosystems: from prehistory to posteradication. Parassitologia (1994) 1.25
How much malaria is there worldwide? Parasitol Today (1989) 1.25
Malarial ecology: a global perspective. Soc Sci Med (1978) 1.23
Changes in the geographical distribution of malaria throughout history. Parassitologia (1989) 1.18
Engineering and malaria control: learning from the past 100 years. Acta Trop (2004) 1.17
The malariology centenary. Parassitologia (1999) 1.13
The puzzling links between malaria transmission and drug resistance. Trends Parasitol (2003) 1.10
Roll back malaria is unarguably both necessary and possible. Bull World Health Organ (2000) 1.07
The present status of malaria in the world. Am J Trop Med Hyg (1952) 1.07
The challenges of doing more against malaria, particularly in Africa. Bull World Health Organ (2000) 1.05
Antimalarial work in China: a historical perspective. Parassitologia (1998) 1.05
World malaria situation in 1992. Part II. Asia west of India. Wkly Epidemiol Rec (1994) 1.02
Human migration, mosquitoes and the evolution of Plasmodium falciparum. Trends Parasitol (2003) 1.01
Tropical medicine: 100 years of progress. Br Med Bull (1998) 0.98
How the Malaria Service in Indonesia came into being, 1898-1948. J Hyg (Lond) (1950) 0.97
Malaria, agriculture, and development: lessons from past campaigns. Int J Health Serv (1987) 0.95
The end of malaria in Europe: an eradication of the disease by control measures. Parassitologia (1998) 0.94
The concept of specificity and the Italian contribution to the discovery of the malaria transmission cycle. Parassitologia (1999) 0.94
Ronald Ross and the malaria-mosquito cycle. Parassitologia (1999) 0.91
The Multilateral Initiative on Malaria: co-ordination and co-operation in international malaria research. Parassitologia (1999) 0.90
Eradication of Malaria. Public Health Rep (1965) 0.90
Malaria along the southernmost fringe of its distribution in Africa: epidemiology and control. Bull World Health Organ (1977) 0.89
International health beyond 2000. Nat Med (1998) 0.89
Dealing with malaria in the last 60 years. A personal experience. Parassitologia (2000) 0.89
World malaria situation in 1993. Part II. Wkly Epidemiol Rec (1996) 0.87
The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (2005) 31.73
A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med (2009) 12.82
Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol (2005) 11.88
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med (2008) 8.95
A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J (2011) 8.65
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet (2008) 8.50
Shrinking the malaria map: progress and prospects. Lancet (2010) 8.21
Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study. Lancet (2007) 7.98
Satellite imagery in the study and forecast of malaria. Nature (2002) 7.84
Climate change and the resurgence of malaria in the East African highlands. Nature (2002) 7.70
The decline in paediatric malaria admissions on the coast of Kenya. Malar J (2007) 7.45
Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med (2010) 7.22
Improved diagnostic testing and malaria treatment practices in Zambia. JAMA (2007) 7.15
Assessment of inpatient paediatric care in first referral level hospitals in 13 districts in Kenya. Lancet (2004) 7.13
Increasing coverage and decreasing inequity in insecticide-treated bed net use among rural Kenyan children. PLoS Med (2007) 6.92
Insecticide-treated net coverage in Africa: mapping progress in 2000-07. Lancet (2008) 6.91
The burden of malaria mortality among African children in the year 2000. Int J Epidemiol (2006) 6.64
Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis (2008) 6.53
Operational strategies to achieve and maintain malaria elimination. Lancet (2010) 6.48
The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis (2010) 6.23
Scaling-up coverage with insecticide-treated nets against malaria in Africa: who should pay? Lancet Infect Dis (2003) 5.74
The malaria Atlas Project: developing global maps of malaria risk. PLoS Med (2006) 5.51
The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial. Lancet (2011) 5.42
Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol (2007) 5.40
Global data for ecology and epidemiology: a novel algorithm for temporal Fourier processing MODIS data. PLoS One (2008) 5.36
Forecasting, warning, and detection of malaria epidemics: a case study. Lancet (2003) 5.27
A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis (2012) 5.24
Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med (2010) 4.89
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J (2007) 4.85
Quantifying the impact of human mobility on malaria. Science (2012) 4.60
Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis (2005) 4.44
Mapping the global extent of malaria in 2005. Trends Parasitol (2006) 4.43
Population distribution, settlement patterns and accessibility across Africa in 2010. PLoS One (2012) 4.34
Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet (2005) 4.22
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study. Malar J (2007) 4.21
Delivery of paediatric care at the first-referral level in Kenya. Lancet (2004) 4.16
Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis (2003) 4.10
Ranking of elimination feasibility between malaria-endemic countries. Lancet (2010) 4.05
Athletics: momentous sprint at the 2156 Olympics? Nature (2004) 3.90
Standardizing estimates of the Plasmodium falciparum parasite rate. Malar J (2007) 3.87
International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission. PLoS Med (2008) 3.86
Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study. BMJ (2005) 3.80
Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med (2010) 3.78
Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Malar J (2008) 3.73
High resolution population maps for low income nations: combining land cover and census in East Africa. PLoS One (2007) 3.65
Defining and detecting malaria epidemics in the highlands of western Kenya. Emerg Infect Dis (2002) 3.55
Improving imperfect data from health management information systems in Africa using space-time geostatistics. PLoS Med (2006) 3.53
Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev (2004) 3.45
Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project. Malar J (2007) 3.42
Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am J Trop Med Hyg (2007) 3.29
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar J (2008) 3.25
Predicting changing malaria risk after expanded insecticide-treated net coverage in Africa. Trends Parasitol (2009) 3.25
Modelling distances travelled to government health services in Kenya. Trop Med Int Health (2006) 3.22
Malaria prevention in highland Kenya: indoor residual house-spraying vs. insecticide-treated bednets. Trop Med Int Health (2002) 3.20
Malaria misdiagnosis in Uganda--implications for policy change. Malar J (2009) 3.19
The use of formal and informal curative services in the management of paediatric fevers in four districts in Kenya. Trop Med Int Health (2003) 3.19
Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial. Am J Trop Med Hyg (2009) 3.17
Defining approaches to settlement mapping for public health management in Kenya using medium spatial resolution satellite imagery. Remote Sens Environ (2004) 3.17
Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis (2005) 3.12
Hot topic or hot air? Climate change and malaria resurgence in East African highlands. Trends Parasitol (2002) 3.10
Climate change and the global malaria recession. Nature (2010) 3.10
How absolute is zero? An evaluation of historical and current definitions of malaria elimination. Malar J (2010) 3.05
Meteorologic influences on Plasmodium falciparum malaria in the Highland Tea Estates of Kericho, Western Kenya. Emerg Infect Dis (2002) 3.02
Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. Am J Trop Med Hyg (2009) 2.84
Impact of malaria control on childhood anaemia in Africa -- a quantitative review. Trop Med Int Health (2004) 2.80
Heterogeneous mobile phone ownership and usage patterns in Kenya. PLoS One (2012) 2.78
Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax. Parasit Vectors (2011) 2.78